T-CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial tests better chemo for Kids' cancer
Disease control Recruiting nowThis study compares two different chemotherapy approaches for children with newly diagnosed T-cell lymphoblastic lymphoma, a type of blood cancer. Researchers want to see which method works better at keeping the cancer from coming back while potentially causing fewer side effects…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Scientists re-engineer Patients' own cells to fight aggressive blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new personalized cell therapy for children and adults with T-cell leukemia or lymphoma that has come back or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the canc…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough childhood cancers: trial tests aggressive drug combo
Disease control Recruiting nowThis study is testing whether a combination of three drugs—calaspargase pegol-mknl, decitabine, and venetoclax—can help control aggressive T-cell blood cancers that have returned or not responded to prior treatment in patients aged 1 month to 21 years. The main goals are to see i…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC